FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998828611> ?p ?o ?g. }

• W2998828611 endingPage "367" @default.
• W2998828611 startingPage "355" @default.
• W2998828611 abstract "Hepatocellular carcinoma (HCC), the sixth most common malignancy worldwide, is characterized by a dismal prognosis due to high recurrence and metastasis rates. Thus, the need for the development of novel chemotherapeutic drugs is urgent. Cyclovirobuxine D (CVB-D), a steroidal alkaloid extracted from Buxus microphylla that has been extensively used to relieve the symptoms of cardiovascular diseases, has shown promising antineoplastic effects in recent studies. However, the therapeutic effects and underlying mechanisms of CVB-D on HCC remain largely unelucidated. This study experimentally indicated that CVB-D can repress HCC cell proliferation by arresting the cell cycle in G2 phase and can facilitate apoptosis. In addition, the migratory and invasive capabilities of HCC cells were noticeably attenuated by a nonlethal dose of CVB-D, and this attenuation was correlated with the inhibition of epithelial-mesenchymal transition (EMT). Moreover, in vivo, CVB-D displayed excellent anticancer effects in HCC tumor-bearing nude mice. Regarding the molecular mechanisms of CVB-D activity, decreased Slug expression was determined to be associated with the aforementioned anti-HCC functions of this extract, which might be regulated by epidermal growth factor receptor (EGFR) through the focal adhesion kinase (FAK)-associated PI3K/AKT and MEK/ERK1/2 signaling pathways. Collectively, our results revealed the suppressive effects of CVB-D on progressive behaviors of HCC, including proliferation, migration, invasion, and EMT, in addition to its outstanding proapoptotic effects, which were correlated with the inhibition of the EGFR-FAK-AKT/ERK1/2-Slug signaling pathway. These discoveries provide an experimental and theoretical foundation for the use of CVB-D as a promising candidate for HCC therapy." @default.
• W2998828611 created "2020-01-23" @default.
• W2998828611 creator A5000206944 @default.
• W2998828611 creator A5000455963 @default.
• W2998828611 creator A5027857766 @default.
• W2998828611 creator A5049605332 @default.
• W2998828611 creator A5055055017 @default.
• W2998828611 creator A5062331088 @default.
• W2998828611 creator A5071773009 @default.
• W2998828611 creator A5054418391 @default.
• W2998828611 date "2020-03-01" @default.
• W2998828611 modified "2023-10-16" @default.
• W2998828611 title "Cyclovirobuxine D Exerts Anticancer Effects by Suppressing the EGFR-FAK-AKT/ERK1/2-Slug Signaling Pathway in Human Hepatocellular Carcinoma" @default.
• W2998828611 cites W1124790770 @default.
• W2998828611 cites W1482137903 @default.
• W2998828611 cites W1551181565 @default.
• W2998828611 cites W1585168055 @default.
• W2998828611 cites W1686134619 @default.
• W2998828611 cites W1952688415 @default.
• W2998828611 cites W1985059554 @default.
• W2998828611 cites W1988759602 @default.
• W2998828611 cites W2009670286 @default.
• W2998828611 cites W2017592190 @default.
• W2998828611 cites W2033293619 @default.
• W2998828611 cites W2035512663 @default.
• W2998828611 cites W2038047082 @default.
• W2998828611 cites W2055049583 @default.
• W2998828611 cites W2060123703 @default.
• W2998828611 cites W2067972848 @default.
• W2998828611 cites W2070081373 @default.
• W2998828611 cites W2071144156 @default.
• W2998828611 cites W2072028737 @default.
• W2998828611 cites W2072430576 @default.
• W2998828611 cites W2074600678 @default.
• W2998828611 cites W2085724471 @default.
• W2998828611 cites W2086240498 @default.
• W2998828611 cites W2097419166 @default.
• W2998828611 cites W2113657698 @default.
• W2998828611 cites W2116213044 @default.
• W2998828611 cites W2140765540 @default.
• W2998828611 cites W2163335322 @default.
• W2998828611 cites W2172812923 @default.
• W2998828611 cites W2215047099 @default.
• W2998828611 cites W2274774578 @default.
• W2998828611 cites W2340909115 @default.
• W2998828611 cites W2343898601 @default.
• W2998828611 cites W2344469861 @default.
• W2998828611 cites W2412738780 @default.
• W2998828611 cites W2416980505 @default.
• W2998828611 cites W2516042533 @default.
• W2998828611 cites W2516849910 @default.
• W2998828611 cites W2529646902 @default.
• W2998828611 cites W2618584271 @default.
• W2998828611 cites W2624883208 @default.
• W2998828611 cites W2691511139 @default.
• W2998828611 cites W2755577506 @default.
• W2998828611 cites W2762044536 @default.
• W2998828611 cites W2762098640 @default.
• W2998828611 cites W2762326631 @default.
• W2998828611 cites W2791095647 @default.
• W2998828611 cites W2797826460 @default.
• W2998828611 cites W2803957887 @default.
• W2998828611 cites W2888487664 @default.
• W2998828611 cites W2889919103 @default.
• W2998828611 cites W2900688774 @default.
• W2998828611 cites W2917783923 @default.
• W2998828611 cites W2938674411 @default.
• W2998828611 cites W2944333152 @default.
• W2998828611 cites W2947357138 @default.
• W2998828611 cites W4210986718 @default.
• W2998828611 doi "https://doi.org/10.1089/dna.2019.4990" @default.
• W2998828611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31913706" @default.
• W2998828611 hasPublicationYear "2020" @default.
• W2998828611 type Work @default.
• W2998828611 sameAs 2998828611 @default.
• W2998828611 citedByCount "12" @default.
• W2998828611 countsByYear W29988286112020 @default.
• W2998828611 countsByYear W29988286112021 @default.
• W2998828611 countsByYear W29988286112022 @default.
• W2998828611 countsByYear W29988286112023 @default.
• W2998828611 crossrefType "journal-article" @default.
• W2998828611 hasAuthorship W2998828611A5000206944 @default.
• W2998828611 hasAuthorship W2998828611A5000455963 @default.
• W2998828611 hasAuthorship W2998828611A5027857766 @default.
• W2998828611 hasAuthorship W2998828611A5049605332 @default.
• W2998828611 hasAuthorship W2998828611A5054418391 @default.
• W2998828611 hasAuthorship W2998828611A5055055017 @default.
• W2998828611 hasAuthorship W2998828611A5062331088 @default.
• W2998828611 hasAuthorship W2998828611A5071773009 @default.
• W2998828611 hasConcept C121608353 @default.
• W2998828611 hasConcept C151166631 @default.
• W2998828611 hasConcept C170493617 @default.
• W2998828611 hasConcept C190283241 @default.
• W2998828611 hasConcept C2778019345 @default.
• W2998828611 hasConcept C2779013556 @default.
• W2998828611 hasConcept C2779438470 @default.
• W2998828611 hasConcept C29537977 @default.
• W2998828611 hasConcept C502942594 @default.

• next